155 related articles for article (PubMed ID: 35115239)
1. Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report.
Arai T; Mukai S; Kazama R; Ogawa Y; Nishida K; Hatanaka K; Gohma I
J Infect Chemother; 2022 Jun; 28(6):810-813. PubMed ID: 35115239
[TBL] [Abstract][Full Text] [Related]
2. A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy.
Kamegai K; Iwamoto N; Togano T; Maeda K; Takamatsu Y; Miyazato Y; Ishikane M; Mizokami M; Sugiyama M; Iida S; Miyamoto S; Suzuki T; Ohmagari N
Int J Infect Dis; 2022 Aug; 121():85-88. PubMed ID: 35500795
[TBL] [Abstract][Full Text] [Related]
3. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.
Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X
Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635
[TBL] [Abstract][Full Text] [Related]
4. Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab.
Franceschini E; Pellegrino M; Todisco V; Dolci G; Bettelli F; Meschiari M; Bedini A; Fregni-Serpini G; Grottola A; Guaraldi G; Pecorari M; Sarti M; Luppi M; Perno CF; Mussini C
Infection; 2023 Oct; 51(5):1577-1581. PubMed ID: 37076752
[TBL] [Abstract][Full Text] [Related]
5. Prolonged infective SARS-CoV-2 omicron variant shedding in a patient with diffuse large B cell lymphoma successfully cleared after three courses of remdesivir.
Nakamura K; Sugiyama M; Ishizuka H; Sasajima T; Minakawa Y; Sato H; Miyazawa M; Kitakawa K; Fujita S; Saito N; Kashiwabara N; Kohata H; Hara Y; Kanari Y; Shinka T; Kanemitsu K
J Infect Chemother; 2023 Aug; 29(8):820-824. PubMed ID: 37182841
[TBL] [Abstract][Full Text] [Related]
6. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N
J Infect Chemother; 2021 Feb; 27(2):387-389. PubMed ID: 33328135
[TBL] [Abstract][Full Text] [Related]
7. Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19).
Kim DY; Lin MY; Jennings C; Li H; Jung JH; Moore NM; Ghinai I; Black SR; Zaccaro DJ; Brofman J; Hayden MK;
Clin Infect Dis; 2023 Feb; 76(3):e416-e425. PubMed ID: 35607802
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.
Yan D; Liu XY; Zhu YN; Huang L; Dan BT; Zhang GJ; Gao YH
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430428
[TBL] [Abstract][Full Text] [Related]
9. Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma.
Ueda Y; Asakura S; Wada S; Saito T; Yano T
Intern Med; 2022 Aug; 61(16):2523-2526. PubMed ID: 35650124
[TBL] [Abstract][Full Text] [Related]
10. Deficient DNA mismatch repair and persistence of SARS-CoV-2 RNA shedding: a case report of hereditary nonpolyposis colorectal cancer with COVID-19 infection.
Haque F; Lillie P; Haque F; Maraveyas A
BMC Infect Dis; 2021 Aug; 21(1):854. PubMed ID: 34418963
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms.
Amanati A; Shahriari M; Bordbar MR; Hedayati SB; Ziyaeyan M; Jamalidoust M; Kalani M; Heydari Marandi N
J Med Case Rep; 2023 Feb; 17(1):66. PubMed ID: 36765433
[TBL] [Abstract][Full Text] [Related]
12. The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study.
Sepulcri C; Dentone C; Mikulska M; Bruzzone B; Lai A; Fenoglio D; Bozzano F; Bergna A; Parodi A; Altosole T; Delfino E; Bartalucci G; Orsi A; Di Biagio A; Zehender G; Ballerini F; Bonora S; Sette A; De Palma R; Silvestri G; De Maria A; Bassetti M
Open Forum Infect Dis; 2021 Nov; 8(11):ofab217. PubMed ID: 34796242
[TBL] [Abstract][Full Text] [Related]
13. Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values.
Thornton CS; Huntley K; Berenger BM; Bristow M; Evans DH; Fonseca K; Franko A; Gillrie MR; Lin YC; Povitz M; Shafey M; Conly JM; Tremblay A
Antimicrob Resist Infect Control; 2022 Feb; 11(1):28. PubMed ID: 35123573
[TBL] [Abstract][Full Text] [Related]
14. Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient.
Shoji K; Suzuki A; Okamoto M; Tsinda EK; Sugawara N; Sasaki M; Nogami Y; Kobayashi M; Oshitani H; Yanai M
J Infect Chemother; 2022 Jul; 28(7):1001-1004. PubMed ID: 35430092
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).
Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L
Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376
[TBL] [Abstract][Full Text] [Related]
16. Viral Haplotypes in COVID-19 Patients Associated With Prolonged Viral Shedding.
Wu Y; Zheng S; Liu T; Liu X; Tang H; He Y; Xu W; Li L; Yu W; Xing K; Xia X
Front Cell Infect Microbiol; 2021; 11():715143. PubMed ID: 34858866
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
Zimmerli A; Monti M; Fenwick C; Eckerle I; Beigelman-Aubry C; Pellaton C; Jaton K; Dumas D; Stamm GM; Infanti L; Andreu-Ullrich H; Germann D; Mean M; Vollenweider P; Stadelmann R; Prella M; Comte D; Guery B; Gachoud D; Rufer N
Front Immunol; 2021; 12():613502. PubMed ID: 33968017
[TBL] [Abstract][Full Text] [Related]
18. Prolonged SARS-CoV-2 infection during obinutuzumab and bendamustine treatment for follicular lymphoma: A case report.
Kambe R; Sato M; Uehara D; Iizuka Y; Kakizaki S
Clin Case Rep; 2023 Sep; 11(9):e7861. PubMed ID: 37649899
[TBL] [Abstract][Full Text] [Related]
19. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
Chen Y; Chen L; Deng Q; Zhang G; Wu K; Ni L; Yang Y; Liu B; Wang W; Wei C; Yang J; Ye G; Cheng Z
J Med Virol; 2020 Jul; 92(7):833-840. PubMed ID: 32243607
[TBL] [Abstract][Full Text] [Related]
20. Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms/signs.
Park SY; Yun SG; Shin JW; Lee BY; Son HJ; Lee S; Lee E; Kim TH
Korean J Intern Med; 2020 Jul; 35(4):793-796. PubMed ID: 32549526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
